– Topline Results from SHINE Study in Mild-to-Moderate Alzheimer’s Expected mid-2024 –
– On Track to Report Topline Results from SHIMMER Study in Mild-to-Moderate DLB in 2H 2024 –
– 1Q 2024 Capital Raise Extends Cash Runway Through May 2025 –
– Webcast Conference Call Scheduled Today at 8:00 a.m. ET –
NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.
